Market News
Stay updated with the latest market trends, earnings, and economic indicators.
IRDAI Receives First Wave Of Applications Under 100% Insurance FDI Regime: Sources
The influx of applications follows the historic operationalization of the 100% Foreign Direct Investment (FDI) policy in the insurance sector earlier this year.
Adani Group to invest Rs 90,000-Rs 1 lakh crore across airports in next 5 years as Mundra commercial operations take off
Adani Group plans a massive Rs 90,000-1 lakh crore investment in its airports over five years, Jeet Adani revealed. The group will aggressively bid for 11 new airports as the government opens private bidding. This expansion aims to significantly boost India's aviation economy. The launch of commercial flights from Mundra airport, connecting to Mumbai and Goa, marks a key step in transforming the region into a logistics hub.
Sun Pharma To Acquire 100% Share In Invocare Lifesciences For Rs 271 Crore
Sun Pharma described the acquisition as a strategic investment to strengthen its product portfolio.
KKR eyes at least $1 billion stake in Medicover's India hospital arm, source says
Global investment firm KKR is in advanced discussions to acquire a significant stake in Medicover's Indian hospital operations. The deal is valued at over one billion dollars. Medicover, a Swedish healthcare group, confirmed these talks. This potential acquisition marks a substantial expansion for KKR in India's growing healthcare sector.
Krishna Institute of Medical Sciences gains on launching QIP
Krishna Institute of Medical Sciences rose 1.03% to Rs 786.20 after its Finance & Investment Committee approved the launch of a qualified institutional placement (QIP) and fixed the floor price at Rs 771.73 per equity share.
CCI clears TVS Group's acquisition of PGIM India AMC, Temasek-Romsons deal
India's fair trade regulator CCI has given the green light for TVS Group entities to acquire PGIM India Asset Management. The regulator also cleared Temasek's investment in medical devices maker Romsons Group. These approvals pave the way for significant business consolidations in the financial and healthcare sectors. The deals involve substantial stake acquisitions and restructuring.
Rs 1 Lakh To Rs 3 Lakh: The Rule Of 114 Can Tell You How Long It May Take
The Rule of 114 is a widely used personal finance formula that helps investors calculate the approximate number of years required for their investment to grow three times at a fixed annual rate of return.
Why Bajaj Finserv AMC is bullish on banks, NBFCs and the Indian market
Nimesh Chandan, Chief Investment Officer at Bajaj Finserv AMC, said the recent correction has created opportunities in select gold financing companies. However, the fund house remains relatively cautious on jewellery stocks and is more constructive on gold financiers from a long-term perspective.
AB Group reaffirms bet on Voda Idea with ₹4,730 Cr infusion
Vodafone Idea shareholders approved a ₹4,730-crore investment from the Aditya Birla Group via preferential allotment of warrants, increasing AB Group's stake to around 13%. Chairman Kumar Mangalam Birla stated the company's focus now shifts to execution across operations, customer service, and network expansion. This capital infusion will support capital expenditure and loan repayment, reinforcing Vi's financial health.
India needs to remain attractive for innovation-led investment: Judith Love, Novartis
With an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The company underscores the importance of collaboration to tackle obstacles like high costs and inadequate infrastructure.
Carlyle Eyes India IPO For Healthcare RCM Provider After Recent Acquisition
Carlyle has started discussions with investment banks for a possible India IPO of its healthcare billing venture.
Uzbekistan can provide more incentives to Indian pharma firms, aims to become regional hub for supply
Uzbekistan is inviting Indian drug companies to invest more. They are offering better subsidies and technology help. This aims to make Uzbekistan a key hub for making and supplying medicines in the region. Simplified rules and tax benefits will encourage more investment. This move will boost local healthcare and strengthen trade ties between the two nations.